ID   FCN1_HUMAN              Reviewed;         326 AA.
AC   O00602; Q5VYV5; Q92596;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   03-AUG-2022, entry version 187.
DE   RecName: Full=Ficolin-1;
DE   AltName: Full=Collagen/fibrinogen domain-containing protein 1;
DE   AltName: Full=Ficolin-A;
DE   AltName: Full=Ficolin-alpha;
DE   AltName: Full=M-ficolin;
DE   Flags: Precursor;
GN   Name=FCN1; Synonyms=FCNM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Uterus;
RX   PubMed=8573080; DOI=10.1042/bj3130473;
RA   Lu J., Tay P.N., Kon O.L., Reid K.B.;
RT   "Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes
RT   as the major site of synthesis and assignment of the gene to chromosome
RT   9.";
RL   Biochem. J. 313:473-478(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-326.
RC   TISSUE=Uterus;
RX   PubMed=8947836; DOI=10.1093/oxfordjournals.jbchem.a021474;
RA   Harumiya S., Takeda K., Sugiura T., Fukumoto Y., Tachikawa H., Miyazono K.,
RA   Fujimoto D., Ichijo H.;
RT   "Characterization of ficolins as novel elastin-binding proteins and
RT   molecular cloning of human ficolin-1.";
RL   J. Biochem. 120:745-751(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 30-44.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CRP AND FFAR2.
RX   PubMed=21037097; DOI=10.4049/jimmunol.1001225;
RA   Zhang J., Yang L., Ang Z., Yoong S.L., Tran T.T., Anand G.S., Tan N.S.,
RA   Ho B., Ding J.L.;
RT   "Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled
RT   receptor 43 and cross talks with plasma C-reactive protein to mediate
RT   immune signaling and regulate host defense.";
RL   J. Immunol. 185:6899-6910(2010).
RN   [9]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=20400674; DOI=10.1189/jlb.1209802;
RA   Honore C., Rorvig S., Hummelshoj T., Skjoedt M.O., Borregaard N.,
RA   Garred P.;
RT   "Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid
RT   by the fibrinogen-like domain.";
RL   J. Leukoc. Biol. 88:145-158(2010).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 115-326 IN COMPLEX WITH CALCIUM,
RP   SUBUNIT, DISULFIDE BONDS, CALCIUM-BINDING SITES, PH-DEPENDENCY, AND DOMAIN.
RX   PubMed=17148457; DOI=10.1074/jbc.m608627200;
RA   Tanio M., Kondo S., Sugio S., Kohno T.;
RT   "Trivalent recognition unit of innate immunity system: crystal structure of
RT   trimeric human M-ficolin fibrinogen-like domain.";
RL   J. Biol. Chem. 282:3889-3895(2007).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 109-326 IN COMPLEX WITH CALCIUM
RP   AND CARBOHYDRATE, SUBUNIT, DISULFIDE BONDS, CALCIUM-BINDING SITES,
RP   PH-DEPENDENCY, AND DOMAIN.
RX   PubMed=17897951; DOI=10.1074/jbc.m705741200;
RA   Garlatti V., Martin L., Gout E., Reiser J.B., Fujita T., Arlaud G.J.,
RA   Thielens N.M., Gaboriaud C.;
RT   "Structural basis for innate immune sensing by M-ficolin and its control by
RT   a pH-dependent conformational switch.";
RL   J. Biol. Chem. 282:35814-35820(2007).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.21 ANGSTROMS) OF 110-326 IN COMPLEX WITH CALCIUM,
RP   DISULFIDE BONDS, FUNCTION, SUBUNIT, SUBSTRATE SPECIFICITY, CALCIUM-BINDING
RP   SITES, AND MUTAGENESIS OF GLY-250; ALA-285 AND TYR-300.
RX   PubMed=20032467; DOI=10.1074/jbc.m109.065854;
RA   Gout E., Garlatti V., Smith D.F., Lacroix M., Dumestre-Perard C.,
RA   Lunardi T., Martin L., Cesbron J.Y., Arlaud G.J., Gaboriaud C.,
RA   Thielens N.M.;
RT   "Carbohydrate recognition properties of human ficolins: glycan array
RT   screening reveals the sialic acid binding specificity of M-ficolin.";
RL   J. Biol. Chem. 285:6612-6622(2010).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-175.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Extracellular lectin functioning as a pattern-recognition
CC       receptor in innate immunity. Binds the sugar moieties of pathogen-
CC       associated molecular patterns (PAMPs) displayed on microbes and
CC       activates the lectin pathway of the complement system. May also
CC       activate monocytes through a G protein-coupled receptor, FFAR2,
CC       inducing the secretion of interleukin-8/IL-8 (PubMed:21037097). Binds
CC       preferentially to 9-O-acetylated 2-6-linked sialic acid derivatives and
CC       to various glycans containing sialic acid engaged in a 2-3 linkage.
CC       {ECO:0000269|PubMed:20032467, ECO:0000269|PubMed:21037097}.
CC   -!- SUBUNIT: Homotrimer (PubMed:17897951). Interacts with elastin/ELN.
CC       Interacts (via Fibrinogen C-terminal domain) with FFAR2. Interacts with
CC       CRP; may regulate monocyte activation by FCN1.
CC       {ECO:0000269|PubMed:17148457, ECO:0000269|PubMed:17897951,
CC       ECO:0000269|PubMed:20032467, ECO:0000269|PubMed:21037097}.
CC   -!- INTERACTION:
CC       O00602; P02741: CRP; NbExp=4; IntAct=EBI-5282479, EBI-1395983;
CC       O00602; P26022: PTX3; NbExp=3; IntAct=EBI-5282479, EBI-11574553;
CC       O00602; Q2TS39: CRP-1; Xeno; NbExp=3; IntAct=EBI-5282479, EBI-7468648;
CC       PRO_0000009136; O15552: FFAR2; NbExp=7; IntAct=EBI-11784425, EBI-2833872;
CC       PRO_0000009136; P26022: PTX3; NbExp=7; IntAct=EBI-11784425, EBI-11574553;
CC       PRO_0000009136; P02769: ALB; Xeno; NbExp=2; IntAct=EBI-11784425, EBI-2296927;
CC       PRO_0000009136; PRO_0000000214 [P9WQP3]: fbpA; Xeno; NbExp=2; IntAct=EBI-11784425, EBI-26878164;
CC       PRO_0000009136; P9WQP1: fbpB; Xeno; NbExp=3; IntAct=EBI-11784425, EBI-26878221;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:20400674,
CC       ECO:0000269|PubMed:21037097}. Cell membrane
CC       {ECO:0000269|PubMed:20400674, ECO:0000269|PubMed:21037097}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:20400674,
CC       ECO:0000269|PubMed:21037097}; Extracellular side
CC       {ECO:0000269|PubMed:20400674, ECO:0000269|PubMed:21037097}. Note=Found
CC       on the monocyte and granulocyte surface (PubMed:20400674).
CC   -!- TISSUE SPECIFICITY: Peripheral blood leukocytes, monocytes and
CC       granulocytes. Also detected in spleen, lung, and thymus, may be due to
CC       the presence of tissue macrophages or trapped blood in these tissues.
CC       Not detected on lymphocytes. {ECO:0000269|PubMed:20400674}.
CC   -!- DOMAIN: The fibrinogen C-terminal domain mediates calcium-dependent
CC       binding to carbohydrates and tethering to the cell surface in monocytes
CC       and granulocytes. The domain undergoes a conformational switch at pH
CC       under 6.2, and looses its carbohydrate-binding ability.
CC       {ECO:0000269|PubMed:17148457, ECO:0000269|PubMed:17897951}.
CC   -!- SIMILARITY: Belongs to the ficolin lectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA12120.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S80990; AAB50706.1; -; mRNA.
DR   EMBL; AK314867; BAG37382.1; -; mRNA.
DR   EMBL; AL353611; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88137.1; -; Genomic_DNA.
DR   EMBL; BC020635; AAH20635.1; -; mRNA.
DR   EMBL; D83920; BAA12120.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6985.1; -.
DR   PIR; S61517; S61517.
DR   RefSeq; NP_001994.2; NM_002003.4.
DR   PDB; 2D39; X-ray; 1.90 A; A/B/C=115-326.
DR   PDB; 2JHH; X-ray; 1.70 A; C/F=109-326.
DR   PDB; 2JHI; X-ray; 1.80 A; F=109-326.
DR   PDB; 2JHK; X-ray; 1.75 A; F=109-326.
DR   PDB; 2JHL; X-ray; 1.75 A; F=109-326.
DR   PDB; 2JHM; X-ray; 1.52 A; F=109-326.
DR   PDB; 2WNP; X-ray; 1.21 A; F=110-326.
DR   PDBsum; 2D39; -.
DR   PDBsum; 2JHH; -.
DR   PDBsum; 2JHI; -.
DR   PDBsum; 2JHK; -.
DR   PDBsum; 2JHL; -.
DR   PDBsum; 2JHM; -.
DR   PDBsum; 2WNP; -.
DR   AlphaFoldDB; O00602; -.
DR   BMRB; O00602; -.
DR   SMR; O00602; -.
DR   BioGRID; 108513; 36.
DR   ComplexPortal; CPX-6172; FCN1-MASP1 lectin-protease complex.
DR   ComplexPortal; CPX-6237; FCN1-MASP2 lectin-protease complex.
DR   IntAct; O00602; 54.
DR   MINT; O00602; -.
DR   STRING; 9606.ENSP00000360871; -.
DR   UniLectin; O00602; -.
DR   GlyGen; O00602; 1 site.
DR   PhosphoSitePlus; O00602; -.
DR   BioMuta; FCN1; -.
DR   EPD; O00602; -.
DR   jPOST; O00602; -.
DR   MassIVE; O00602; -.
DR   PaxDb; O00602; -.
DR   PeptideAtlas; O00602; -.
DR   PRIDE; O00602; -.
DR   ProteomicsDB; 47994; -.
DR   Antibodypedia; 602; 401 antibodies from 31 providers.
DR   DNASU; 2219; -.
DR   Ensembl; ENST00000371806.4; ENSP00000360871.3; ENSG00000085265.12.
DR   GeneID; 2219; -.
DR   KEGG; hsa:2219; -.
DR   MANE-Select; ENST00000371806.4; ENSP00000360871.3; NM_002003.5; NP_001994.2.
DR   UCSC; uc004cfi.4; human.
DR   CTD; 2219; -.
DR   DisGeNET; 2219; -.
DR   GeneCards; FCN1; -.
DR   HGNC; HGNC:3623; FCN1.
DR   HPA; ENSG00000085265; Group enriched (bone marrow, lung, lymphoid tissue).
DR   MIM; 601252; gene.
DR   neXtProt; NX_O00602; -.
DR   OpenTargets; ENSG00000085265; -.
DR   PharmGKB; PA28069; -.
DR   VEuPathDB; HostDB:ENSG00000085265; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000157531; -.
DR   HOGENOM; CLU_038628_3_3_1; -.
DR   InParanoid; O00602; -.
DR   OMA; HKSYANG; -.
DR   OrthoDB; 1035379at2759; -.
DR   PhylomeDB; O00602; -.
DR   TreeFam; TF329953; -.
DR   PathwayCommons; O00602; -.
DR   Reactome; R-HSA-166662; Lectin pathway of complement activation.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-2855086; Ficolins bind to repetitive carbohydrate structures on the target cell surface.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; O00602; -.
DR   BioGRID-ORCS; 2219; 9 hits in 1066 CRISPR screens.
DR   EvolutionaryTrace; O00602; -.
DR   GeneWiki; FCN1; -.
DR   GenomeRNAi; 2219; -.
DR   Pharos; O00602; Tbio.
DR   PRO; PR:O00602; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; O00602; protein.
DR   Bgee; ENSG00000085265; Expressed in monocyte and 113 other tissues.
DR   ExpressionAtlas; O00602; baseline and differential.
DR   Genevisible; O00602; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0009897; C:external side of plasma membrane; IC:ComplexPortal.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0031232; C:extrinsic component of external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; IDA:ComplexPortal.
DR   GO; GO:0003823; F:antigen binding; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0097367; F:carbohydrate derivative binding; IBA:GO_Central.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0038187; F:pattern recognition receptor activity; IMP:UniProtKB.
DR   GO; GO:0033691; F:sialic acid binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0001867; P:complement activation, lectin pathway; IDA:ComplexPortal.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:UniProtKB.
DR   GO; GO:1903028; P:positive regulation of opsonization; IDA:ComplexPortal.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:ComplexPortal.
DR   GO; GO:0043654; P:recognition of apoptotic cell; IDA:UniProtKB.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF01391; Collagen; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell membrane; Collagen; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunity; Innate immunity; Lectin; Membrane;
KW   Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           30..326
FT                   /note="Ficolin-1"
FT                   /id="PRO_0000009136"
FT   DOMAIN          55..93
FT                   /note="Collagen-like"
FT   DOMAIN          109..326
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   REGION          72..111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          115..154
FT                   /note="A domain; contributes to trimerization"
FT   REGION          155..243
FT                   /note="B domain; contributes to trimerization"
FT   REGION          317..326
FT                   /note="P domain"
FT                   /evidence="ECO:0000303|PubMed:17148457"
FT   BINDING         262
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2D39, ECO:0007744|PDB:2WNP"
FT   BINDING         264
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2D39, ECO:0007744|PDB:2WNP"
FT   BINDING         266
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2D39, ECO:0007744|PDB:2WNP"
FT   BINDING         268
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2D39, ECO:0007744|PDB:2WNP"
FT   BINDING         282..284
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:17897951"
FT   SITE            300
FT                   /note="Mediates specificity for sialic acids"
FT                   /evidence="ECO:0000305|PubMed:17897951,
FT                   ECO:0000305|PubMed:20032467"
FT   SITE            312
FT                   /note="Mediates specificity for sialic acids"
FT                   /evidence="ECO:0000305|PubMed:17897951"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        111..139
FT                   /evidence="ECO:0000269|PubMed:17897951,
FT                   ECO:0000269|PubMed:20032467, ECO:0007744|PDB:2WNP"
FT   DISULFID        118..146
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2WNP"
FT   DISULFID        270..283
FT                   /evidence="ECO:0000269|PubMed:17148457,
FT                   ECO:0000269|PubMed:17897951, ECO:0000269|PubMed:20032467,
FT                   ECO:0007744|PDB:2WNP"
FT   VARIANT         93
FT                   /note="R -> Q (in dbSNP:rs56345770)"
FT                   /id="VAR_061172"
FT   VARIANT         126
FT                   /note="Y -> H (in dbSNP:rs771359747)"
FT                   /id="VAR_024450"
FT   VARIANT         175
FT                   /note="Y -> C (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036341"
FT   MUTAGEN         250
FT                   /note="G->F: Inhibits binding to the 9-O-acetylated sialic
FT                   acid derivatives."
FT                   /evidence="ECO:0000269|PubMed:20032467"
FT   MUTAGEN         285
FT                   /note="A->V: Inhibits binding to the 9-O-acetylated sialic
FT                   acid derivatives."
FT                   /evidence="ECO:0000269|PubMed:20032467"
FT   MUTAGEN         300
FT                   /note="Y->F: Abolishes interaction with all sialic
FT                   acid-containing glycans."
FT                   /evidence="ECO:0000269|PubMed:20032467"
FT   CONFLICT        133
FT                   /note="T -> N (in Ref. 1; AAB50706)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287
FT                   /note="N -> S (in Ref. 1; AAB50706)"
FT                   /evidence="ECO:0000305"
FT   TURN            111..113
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           118..123
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          130..135
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          141..147
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           150..152
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          155..164
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           172..177
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:2D39"
FT   HELIX           190..198
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          202..209
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          215..221
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           249..251
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          264..268
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   HELIX           270..273
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          298..301
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          303..306
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:2WNP"
FT   STRAND          312..315
FT                   /evidence="ECO:0007829|PDB:2JHK"
FT   STRAND          317..325
FT                   /evidence="ECO:0007829|PDB:2WNP"
SQ   SEQUENCE   326 AA;  35078 MW;  184D24B371B251AB CRC64;
     MELSGATMAR GLAVLLVLFL HIKNLPAQAA DTCPEVKVVG LEGSDKLTIL RGCPGLPGAP
     GPKGEAGVIG ERGERGLPGA PGKAGPVGPK GDRGEKGMRG EKGDAGQSQS CATGPRNCKD
     LLDRGYFLSG WHTIYLPDCR PLTVLCDMDT DGGGWTVFQR RMDGSVDFYR DWAAYKQGFG
     SQLGEFWLGN DNIHALTAQG SSELRVDLVD FEGNHQFAKY KSFKVADEAE KYKLVLGAFV
     GGSAGNSLTG HNNNFFSTKD QDNDVSSSNC AEKFQGAWWY ADCHASNLNG LYLMGPHESY
     ANGINWSAAK GYKYSYKVSE MKVRPA
//
